Differences in perioperative outcomes after laparoscopic management of benign and malignant adnexal masses.
- Author:
Mohamad S GAD
1
;
Nabih I EL KHOULY
;
Enrique SOTO
;
Michael BRODMAN
;
Linus CHUANG
;
Farr R NEZHAT
;
Herbert F GRETZ
Author Information
- Publication Type:Original Article
- Keywords: Laparoscopy; Benign; Malignant; Borderline; Adnexal mass
- MeSH: Female; Humans; Incidence; Intraoperative Complications; Laparoscopy; Laparotomy; Length of Stay; Operative Time; Ovarian Cysts; Ovarian Neoplasms; Postoperative Complications; Retrospective Studies; Rupture
- From:Journal of Gynecologic Oncology 2011;22(1):18-24
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: To compare the feasibility and safety of the laparoscopic management of adnexal masses appearing preoperatively benign with those suspicious for malignancy. METHODS: Retrospective study of 694 women that underwent laparoscopic management of an adnexal mass. RESULTS: Laparoscopic management of an adnexal mass was completed in 678 patients. Six hundred and thirty five patients had benign pathology (91.5%) and 53 (7.6%) had primary ovarian cancers. Sixteen patients (2.3%) were converted to laparotomy; there were 13 intraoperative (1.9%) and 16 postoperative complications (2.3%). Patients divided in 2 groups: benign and borderline/malignant tumors. Patients in the benign group had a higher incidence of ovarian cyst rupture (26% vs. 8.7%, p<0.05). Patients in the borderline/malignant group had a statistically significant higher conversion rate to laparotomy (0.9% vs. 16.9%, p<0.001), postoperative complications (1.9% vs. 12.2%, p<0.05), blood loss, operative time, and duration of hospital stay. The incidence of intraoperative complications was similar between the 2 groups. CONCLUSION: Laparoscopic management of masses that are suspicious for malignancy or borderline pathology is associated with an increased risk in specific intra-operative and post-operative morbidities in comparison to benign masses. Surgeons should tailor the operative risks with their patients according to the preoperative likelihood of the mass being carcinoma or borderline malignancy.
